Crédit: HUG
A study by the HUG, the UNIGE and the EPFL shows that almost all Genevans (93.8%) have antibodies against SARS-CoV 2 but less than one in two (46.7%) have them against the BA.4/BA. Omicron sub-variants. Crédit: HUG - A study by the Geneva University Hospitals (HUG), the Faculty of Medicine of the University of Geneva and the EPFL shows that almost all Genevans (93.8%) have antibodies against SARS-CoV 2, almost three quarters of whom acquired them through an infection. Eight out of ten people have defenses against the Alpha and Delta variants, but less than one in two (46.7%) have them against the BA.4/BA. Omicron sub-variants. The latter are particularly low among children under 12 years of age. The study will be published shortly on the.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
